Literature DB >> 23116466

Compound activity prediction using models of binding pockets or ligand properties in 3D.

Irina Kufareva1, Yu-Chen Chen, Andrey V Ilatovskiy, Ruben Abagyan.   

Abstract

Transient interactions of endogenous and exogenous small molecules with flexible binding sites in proteins or macromolecular assemblies play a critical role in all biological processes. Current advances in high-resolution protein structure determination, database development, and docking methodology make it possible to design three-dimensional models for prediction of such interactions with increasing accuracy and specificity. Using the data collected in the Pocketome encyclopedia, we here provide an overview of two types of the three-dimensional ligand activity models, pocketbased and ligand property-based, for two important classes of proteins, nuclear and G-protein coupled receptors. For half the targets, the pocket models discriminate actives from property matched decoys with acceptable accuracy (the area under ROC curve, AUC, exceeding 84%) and for about one fifth of the targets with high accuracy (AUC > 95%). The 3D ligand property field models performed better than 95% in half of the cases. The high performance models can already become a basis of activity predictions for new chemicals. Family-wide benchmarking of the models highlights strengths of both approaches and helps identify their inherent bottlenecks and challenges.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23116466      PMCID: PMC4085113          DOI: 10.2174/156802612804547335

Source DB:  PubMed          Journal:  Curr Top Med Chem        ISSN: 1568-0266            Impact factor:   3.295


  67 in total

1.  The PDBbind database: collection of binding affinities for protein-ligand complexes with known three-dimensional structures.

Authors:  Renxiao Wang; Xueliang Fang; Yipin Lu; Shaomeng Wang
Journal:  J Med Chem       Date:  2004-06-03       Impact factor: 7.446

2.  MSDsite: a database search and retrieval system for the analysis and viewing of bound ligands and active sites.

Authors:  Adel Golovin; Dimitris Dimitropoulos; Tom Oldfield; Abdelkrim Rachedi; Kim Henrick
Journal:  Proteins       Date:  2005-01-01

3.  The PDBbind database: methodologies and updates.

Authors:  Renxiao Wang; Xueliang Fang; Yipin Lu; Chao-Yie Yang; Shaomeng Wang
Journal:  J Med Chem       Date:  2005-06-16       Impact factor: 7.446

4.  Benchmarking sets for molecular docking.

Authors:  Niu Huang; Brian K Shoichet; John J Irwin
Journal:  J Med Chem       Date:  2006-11-16       Impact factor: 7.446

5.  High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor.

Authors:  Vadim Cherezov; Daniel M Rosenbaum; Michael A Hanson; Søren G F Rasmussen; Foon Sun Thian; Tong Sun Kobilka; Hee-Jung Choi; Peter Kuhn; William I Weis; Brian K Kobilka; Raymond C Stevens
Journal:  Science       Date:  2007-10-25       Impact factor: 47.728

6.  Discovery of diverse thyroid hormone receptor antagonists by high-throughput docking.

Authors:  Matthieu Schapira; Bruce M Raaka; Sharmistha Das; Li Fan; Maxim Totrov; Zhiguo Zhou; Stephen R Wilson; Ruben Abagyan; Herbert H Samuels
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-30       Impact factor: 11.205

7.  Discovery of antiandrogen activity of nonsteroidal scaffolds of marketed drugs.

Authors:  W H Bisson; A V Cheltsov; N Bruey-Sedano; B Lin; J Chen; N Goldberger; L T May; A Christopoulos; J T Dalton; P M Sexton; X-K Zhang; R Abagyan
Journal:  Proc Natl Acad Sci U S A       Date:  2007-07-02       Impact factor: 11.205

8.  BindingDB: a web-accessible database of experimentally determined protein-ligand binding affinities.

Authors:  Tiqing Liu; Yuhmei Lin; Xin Wen; Robert N Jorissen; Michael K Gilson
Journal:  Nucleic Acids Res       Date:  2006-12-01       Impact factor: 16.971

9.  PDBSite: a database of the 3D structure of protein functional sites.

Authors:  Vladimir A Ivanisenko; Sergey S Pintus; Dmitry A Grigorovich; Nickolay A Kolchanov
Journal:  Nucleic Acids Res       Date:  2005-01-01       Impact factor: 16.971

10.  In silico discovery of novel retinoic acid receptor agonist structures.

Authors:  M Schapira; B M Raaka; H H Samuels; R Abagyan
Journal:  BMC Struct Biol       Date:  2001-06-04
View more
  10 in total

Review 1.  Leveraging structure for enzyme function prediction: methods, opportunities, and challenges.

Authors:  Matthew P Jacobson; Chakrapani Kalyanaraman; Suwen Zhao; Boxue Tian
Journal:  Trends Biochem Sci       Date:  2014-07-02       Impact factor: 13.807

2.  Docking to multiple pockets or ligand fields for screening, activity prediction and scaffold hopping.

Authors:  Yu-Chen Chen; Max Totrov; Ruben Abagyan
Journal:  Future Med Chem       Date:  2014       Impact factor: 3.808

3.  In silico identification and pharmacological evaluation of novel endocrine disrupting chemicals that act via the ligand-binding domain of the estrogen receptor α.

Authors:  Fiona M McRobb; Irina Kufareva; Ruben Abagyan
Journal:  Toxicol Sci       Date:  2014-06-13       Impact factor: 4.849

4.  Stoichiometry and geometry of the CXC chemokine receptor 4 complex with CXC ligand 12: molecular modeling and experimental validation.

Authors:  Irina Kufareva; Bryan S Stephens; Lauren G Holden; Ling Qin; Chunxia Zhao; Tetsuya Kawamura; Ruben Abagyan; Tracy M Handel
Journal:  Proc Natl Acad Sci U S A       Date:  2014-12-02       Impact factor: 11.205

5.  Quantum Mechanics Approaches to Drug Research in the Era of Structural Chemogenomics.

Authors:  Andrey V Ilatovskiy; Ruben Abagyan; Irina Kufareva
Journal:  Int J Quantum Chem       Date:  2013-06-15       Impact factor: 2.444

6.  Structural biology. Crystal structure of the chemokine receptor CXCR4 in complex with a viral chemokine.

Authors:  Ling Qin; Irina Kufareva; Lauren G Holden; Chong Wang; Yi Zheng; Chunxia Zhao; Gustavo Fenalti; Huixian Wu; Gye Won Han; Vadim Cherezov; Ruben Abagyan; Raymond C Stevens; Tracy M Handel
Journal:  Science       Date:  2015-01-22       Impact factor: 47.728

7.  Structure-based predictions of activity cliffs.

Authors:  Jarmila Husby; Giovanni Bottegoni; Irina Kufareva; Ruben Abagyan; Andrea Cavalli
Journal:  J Chem Inf Model       Date:  2015-05-11       Impact factor: 4.956

8.  Experiment-Guided Molecular Modeling of Protein-Protein Complexes Involving GPCRs.

Authors:  Irina Kufareva; Tracy M Handel; Ruben Abagyan
Journal:  Methods Mol Biol       Date:  2015

Review 9.  Drug-Like Protein-Protein Interaction Modulators: Challenges and Opportunities for Drug Discovery and Chemical Biology.

Authors:  Bruno O Villoutreix; Melaine A Kuenemann; Jean-Luc Poyet; Heriberto Bruzzoni-Giovanelli; Céline Labbé; David Lagorce; Olivier Sperandio; Maria A Miteva
Journal:  Mol Inform       Date:  2014-06-02       Impact factor: 3.353

10.  Nilotinib, an approved leukemia drug, inhibits smoothened signaling in Hedgehog-dependent medulloblastoma.

Authors:  Kirti Kandhwal Chahal; Jie Li; Irina Kufareva; Milind Parle; Donald L Durden; Robert J Wechsler-Reya; Clark C Chen; Ruben Abagyan
Journal:  PLoS One       Date:  2019-09-20       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.